 |
|
|
| |
A Randomized, Double-Blind, Placebo Controlled,
Parallel-Group, Phase II Trial of JKB-121 for the Treatment of
Nonalcoholic Steatohepatitis (NASH)
|
| |
| |
International Liver Congress™ 2018,
European Association for the Study of the Liver (EASL)
April 11th-15th, 2018
Paris, France
Anna Mae Diehl, Stephen Harrison, Stephen Caldwell, Mary Rinella, Angelo Paredes,
Cynthia A. Moylan, Cynthia D. Guy, Mustafa R. Bashir, Ying Wang,
Loren Miller*, Anchi Chang*, Edwin SC Wu*, Manal F. Abdelmalek
Funding Organization: TaiwanJ Pharmaceuticals*
|
| |
|
|
|
|
|
